Best Practice & Research Clinical Rheumatology
Volume 23, Issue 2 , Pages 233-255 , April 2009

How to perform and analyse biopsies in relation to connective tissue diseases

  • Evelien Ton, MD (Rheumatlogist)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +31 88 7557357; Fax: +31 30 2523741.
  • ,
  • Aike A. Kruize, MD, PhD (Rheumatlogist)

References 

  1. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347(4):261–271
  2. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372(9634):234–245
  3. Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum. 1984;13(4):322–328
  4. Bird HA, Esselinckx W, Dixon AS, et al. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis. 1979;38(5):434–439
  5. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982;97(5):672–680
  6. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122–1128
  7. Bleeker-Rovers CP, Vos FJ, de Kleijn EM, et al. A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore). 2007;86(1):26–38
  8. Dasgupta B, Hassan N. Giant cell arteritis: recent advances and guidelines for management. Clin Exp Rheumatol. 2007;25(1 Suppl. 44):S62–S65
  9. Salvarani C, Silingardi M, Ghirarduzzi A, et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?. Ann Intern Med. 2002;137(4):232–238
  10. Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med. 2005;142(5):359–369
  11. Bley TA, Weiben O, Uhl M, et al. Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging. Arthritis Rheum. 2005;52(8):2470–2477
  12. Bley TA, Wieben O, Uhl M, et al. High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol. 2005;184(1):283–287
  13. Schmid R, Hermann M, Yannar A, Baumgartner RW. Colour duplex ultrasound of the temporal artery: replacement for biopsy in temporal arteritis, Ophthalmologica. 2002;216(1):16–21
  14. Schmidt WA, Kraft HE, Vorpahl K, et al. Colour duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med. 1997;337(19):1336–1342
  15. Alberts MS, Mosen DM. Diagnosing temporal arteritis: duplex vs. biopsy. QJM. 2007;100(12):785–789
  16. Bley TA, Reinhard M, Hauenstein C, et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum. 2008;58(8):2574–2578
  17. Rodon P, Friocourt P, Blanchet S, Levallois D. Temporal artery involvement revealing AL amyloidosis and IgD monoclonal gammopathy. J Rheumatol. 1996;23(1):189–190
  18. Rao JK, Allen NB. Primary systemic amyloidosis masquerading as giant cell arteritis. Case report and review of the literature. Arthritis Rheum. 1993;36(3):422–425
  19. Nishino H, DeRemee RA, Rubino FA, Parisi JE. Wegener's granulomatosis associated with vasculitis of the temporal artery: report of five cases. Mayo Clin Proc. 1993;68(2):115–121
  20. Lie JT. Temporal artery biopsy diagnosis of giant cell arteritis: lessons from 1109 biopsies. Anat Pathol. 1996;1:69–97
  21. Haugeberg G, Bie R, Johnsen V. Vasculitic changes in the temporal artery in polyarteritis nodosa. Scand J Rheumatol. 1997;26(5):383–385
  22. Achkar AA, Hunder GG, Gabriel SE. Effect of previous corticosteroid treatment on temporal artery biopsy results. Ann Intern Med. 1998;128(5):410
  23. Ray-Chaudhuri N, Kine DA, Tijani SO, et al. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol. 2002;86(5):530–532
  24. LeSar CJ, Meier GH, DeMasi RJ, et al. The utility of colour duplex ultrasonography in the diagnosis of temporal arteritis. J Vasc Surg. 2002;36(6):1154–1160
  25. Kent RB, Thomas L. Temporal artery biopsy. Am Surg. 1990;56(1):16–21
  26. Duhaut P, Pinede L, Bornet H, et al. Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe de Recherche sur l'Arterite a Cellules Geantes. Ann Rheum Dis. 1999;58(6):335–341
  27. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362(9388):971–982
  28. van der Meulen MF, Bronner IM, Hoogendijk JE, et al. Polymyositis: an overdiagnosed entity. Neurology. 2003;61(3):316–321
  29. Fraser DD, Frank JA, Dalakas M, et al. Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol. 1991;18(11):1693–1700
  30. Schweitzer ME, Fort J. Cost-effectiveness of MR imaging in evaluating polymyositis. AJR Am J Roentgenol. 1995;165(6):1469–1471
  31. Tomasova Studynkova J, Charvat F, Jarosova K, Vencovsky J. The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology (Oxford). 2007;46(7):1174–1179
  32. Dion E, Cherin P, Payan C, et al. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis. J Rheumatol. 2002;29(9):1897–1906
  33. Dalakas MC. Inflammatory and toxic myopathies. Curr Opin Neurol Neurosurg. 1992;5(5):645–654
  34. Baer AN. Differential diagnosis of idiopathic inflammatory myopathies. Curr Rheumatol Rep. 2006;8(3):178–187
  35. O'Rourke KS, Ike RW. Muscle biopsy. Curr Opin Rheumatol. 1995;7(6):462–468
  36. Dorph C, Nennesmo I, Lundberg IE. Percutaneous conchotome muscle biopsy. A useful diagnostic and assessment tool. J Rheumatol. 2001;28(7):1591–1599
  37. Edwards RH, Round JM, Jones DA. Needle biopsy of skeletal muscle: a review of 10 years experience. Muscle Nerve. 1983;6(9):676–683
  38. Cote AM, Jimenez L, Adelman LS, Munsat TL. Needle muscle biopsy with the automatic Biopty instrument. Neurology. 1992;42(11):2212–2213
  39. O'Rourke KS, Blaivas M, Ike RW. Utility of needle muscle biopsy in a university rheumatology practice. J Rheumatol. 1994;21(3):413–424
  40. Campellone JV, Lacomis D, Giuliani MJ, Oddis CV. Percutaneous needle muscle biopsy in the evaluation of patients with suspected inflammatory myopathy. Arthritis Rheum. 1997;40(10):1886–1891
  41. Albert DA, Rimon D, Silverstein MD. The diagnosis of polyarteritis nodosa. I. A literature-based decision analysis approach. Arthritis Rheum. 1988;31:1117–1127
  42. Albert DA, Rimon D, Silverstein MD. The diagnosis of polyarteritis nodosa. II. A literature-based decision analysis approach. Arthritis Rheum. 1988;31:1118–1134
  43. Maya ID, Maddela P, Barker J, Allon M. Percutaneous renal biopsy: comparison of blind and real-time ultrasound-guided technique. Semin Dial. 2007;20(4):355–358
  44. Cluzel P, Martinez F, Bellin MF, et al. Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: comparison of sampling effectiveness and complications. Radiology. 2000;215(3):689–693
  45. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2):521–530
  46. Shidham GB, Siddiqi N, Beres JA, et al. Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology (Carlton). 2005;10(3):305–310
  47. Manno C, Strippoli GF, Arnesano L, et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 2004;66(4):1570–1577
  48. In:  Bologna JL,  Rapine RP editor. Dermatology. 2nd edn.. Mosby/Elsevier; 2008;
  49. Olbricht S. Biopsy techniques and basic excisions. In:  Bologna JL,  Rapina RP editor. Dermatology. 2nd edn.. Mosby/Elsevier; 2008;
  50. van Woerkom JM, Kruize AA, Barendregt PJ, et al. Clinical significance of quantitative immunohistology in labial salivary glands for diagnosing Sjogren's syndrome. Rheumatology (Oxford). 2006;45:470–477
  51. de Wilde PC, Kater L, Baak JP, et al. A new and highly sensitive immunohistologic diagnostic criterion for Sjogren's syndrome. Arthritis Rheum. 1989;32:1214–1220
  52. van G, Hazenberg BP, Bijzet J, van Rijswijk MH. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum. 2006;54(6):2015–2021
  53. Pijpe J, Kalk WW, van der Wal JE, et al. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome. Rheumatology (Oxford). 2007;46(2):335–341
  54. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjogren's disease. J Clin Pathol. 1968;21(5):656–660
  55. Kraaijenhagen HA. Letter: technique for parotid biopsy. J Oral Surg. 1975;33(5):328
  56. Hilton DA, Jacob J, Househam L, Tengah C. Complications following sural and peroneal nerve biopsies. J Neurol Neurosurg Psychiatry. 2007;78:1271–1272
  57. Ruth A, Schulmeyer FJ, Roesch M, et al. Diagnostic and therapeutic value due to suspected diagnosis, long-term complications, and indication for sural nerve biopsy. Clin Neurol Neurosurg. 2005;107(3):214–217
  58. Terrier B, Lacroix C, Guillevin L, et al. Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjogren's syndrome-related neuropathy. Arthritis Rheum. 2007;57(8):1520–1529
  59. Bevilacqua NJ, Rogers LC, Malik RA, Armstrong DG. Technique of the sural nerve biopsy. J Foot Ankle Surg. 2007;46(2):139–142
  60. Dyck PJ, Dyck PJB, Englestad J. Pathologic alterations in nerves. In: Peripheral neuropathy. 4th edn.. Philadelphia: Elsevier Saunders; 2005;p. 733–741
  61. Antic M, Lautenschlager S, Itin PH. Eosinophilic fasciitis 30 years after - what do we really know? Report of 11 patients and review of the literature. Dermatology. 2006;213(2):93–101
  62. Helfman T, Falanga V. Eosinophilic fasciitis. Clin Dermatol. 1994;12(3):449–455

PII: S1521-6942(09)00029-1

doi: 10.1016/j.berh.2009.03.004

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 2 , Pages 233-255 , April 2009